VANECK VECTORS ETF TR's ticker is ESPO and the CUSIP is 92189F114. A total of 89 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,187,973 | +267.6% | 120,015 | +297.5% | 0.00% | +100.0% |
| Q2 2023 | $1,683,204 | -82.1% | 30,192 | -83.0% | 0.00% | -75.0% |
| Q1 2023 | $9,387,945 | +47.2% | 177,533 | +19.3% | 0.00% | +33.3% |
| Q4 2022 | $6,378,682 | +3.5% | 148,826 | -2.0% | 0.00% | 0.0% |
| Q3 2022 | $6,165,000 | -37.0% | 151,842 | -26.0% | 0.00% | -25.0% |
| Q2 2022 | $9,786,000 | -7.3% | 205,245 | +12.9% | 0.00% | +33.3% |
| Q1 2022 | $10,559,000 | -12.6% | 181,766 | -0.4% | 0.00% | -25.0% |
| Q4 2021 | $12,085,000 | +546.9% | 182,437 | +534.8% | 0.00% | +300.0% |
| Q3 2021 | $1,868,000 | -37.1% | 28,741 | -29.8% | 0.00% | 0.0% |
| Q2 2021 | $2,970,000 | -47.0% | 40,920 | -50.1% | 0.00% | -66.7% |
| Q1 2021 | $5,600,000 | +78.8% | 81,930 | +61.0% | 0.00% | +50.0% |
| Q3 2020 | $3,132,000 | +420.3% | 50,901 | +185.5% | 0.00% | +100.0% |
| Q3 2019 | $602,000 | -7.1% | 17,828 | -12.7% | 0.00% | 0.0% |
| Q1 2019 | $648,000 | +15.3% | 20,426 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $562,000 | – | 20,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Main Management ETF Advisors, LLC | 112,455 | $6,533,000 | 0.61% |
| Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD | 124,482 | $7,177,000 | 0.50% |
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD | 46,343 | $2,672,000 | 0.47% |
| GARRISON POINT ADVISORS, LLC | 8,758 | $509,000 | 0.36% |
| Andesa Financial Management Inc. | 8,585 | $499,000 | 0.27% |
| Rather & Kittrell, Inc. | 3,584 | $208,000 | 0.20% |
| MEITAV INVESTMENT HOUSE LTD | 219,303 | $12,739,000 | 0.19% |
| Jaffetilchin Investment Partners, LLC | 20,801 | $967,000 | 0.11% |
| Laidlaw Wealth Management LLC | 10,316 | $599,000 | 0.10% |
| EXANE DERIVATIVES | 6,000 | $348,519,000 | 0.10% |